nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—DRD2—Signaling by GPCR—GNA11—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—GNAQ—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—GNAQ—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—GNA11—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAML2—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—GNA11—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00113	0.00113	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—GNA11—ocular cancer	0.00113	0.00113	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—GNA11—ocular cancer	0.00113	0.00113	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—GNA11—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TFDP1—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAML2—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—GNAQ—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—E2F3—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—GNAQ—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—GNAQ—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—GNAQ—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—GNA11—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—GNAQ—ocular cancer	0.00105	0.00105	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—E2F3—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—E2F3—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—GNAQ—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—E2F3—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Maprotiline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—E2F3—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—E2F3—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—TP53—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—GNA11—ocular cancer	0.000991	0.000991	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000987	0.000987	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—TP53—ocular cancer	0.000987	0.000987	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TFDP1—ocular cancer	0.000985	0.000985	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—GNAQ—ocular cancer	0.000976	0.000976	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TFDP1—ocular cancer	0.000969	0.000969	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TFDP1—ocular cancer	0.000967	0.000967	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TFDP1—ocular cancer	0.000964	0.000964	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TFDP1—ocular cancer	0.000961	0.000961	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000955	0.000955	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TFDP1—ocular cancer	0.000952	0.000952	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—GNA11—ocular cancer	0.000949	0.000949	CbGpPWpGaD
Maprotiline—SLC6A3—Neuronal System—HRAS—ocular cancer	0.000924	0.000924	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—GNAQ—ocular cancer	0.000922	0.000922	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000908	0.000908	CbGpPWpGaD
Maprotiline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000899	0.000899	CbGpPWpGaD
Maprotiline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000897	0.000897	CbGpPWpGaD
Maprotiline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000894	0.000894	CbGpPWpGaD
Maprotiline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000891	0.000891	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAML2—ocular cancer	0.000887	0.000887	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—GNAQ—ocular cancer	0.000883	0.000883	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HDAC1—ocular cancer	0.00088	0.00088	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HDAC1—ocular cancer	0.000831	0.000831	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GNA11—ocular cancer	0.000797	0.000797	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HDAC1—ocular cancer	0.000795	0.000795	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000791	0.000791	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00079	0.00079	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CDKN2B—ocular cancer	0.000789	0.000789	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAML2—ocular cancer	0.000783	0.000783	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GNA11—ocular cancer	0.000774	0.000774	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAML2—ocular cancer	0.00077	0.00077	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAML2—ocular cancer	0.000769	0.000769	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAML2—ocular cancer	0.000766	0.000766	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAML2—ocular cancer	0.000764	0.000764	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAML2—ocular cancer	0.000756	0.000756	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CDKN2B—ocular cancer	0.000745	0.000745	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GNAQ—ocular cancer	0.000741	0.000741	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—E2F1—ocular cancer	0.000724	0.000724	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GNAQ—ocular cancer	0.000719	0.000719	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CDKN2B—ocular cancer	0.000713	0.000713	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—E2F1—ocular cancer	0.000683	0.000683	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GNA11—ocular cancer	0.000683	0.000683	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GNA11—ocular cancer	0.000672	0.000672	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GNA11—ocular cancer	0.000671	0.000671	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GNA11—ocular cancer	0.000668	0.000668	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GNA11—ocular cancer	0.000666	0.000666	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GNA11—ocular cancer	0.00066	0.00066	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—E2F1—ocular cancer	0.000655	0.000655	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HDAC1—ocular cancer	0.000648	0.000648	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GNAQ—ocular cancer	0.000635	0.000635	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GNAQ—ocular cancer	0.000625	0.000625	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GNAQ—ocular cancer	0.000623	0.000623	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GNAQ—ocular cancer	0.000621	0.000621	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GNAQ—ocular cancer	0.000619	0.000619	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GNAQ—ocular cancer	0.000613	0.000613	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CDKN2B—ocular cancer	0.000581	0.000581	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HDAC1—ocular cancer	0.000572	0.000572	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HDAC1—ocular cancer	0.000563	0.000563	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HDAC1—ocular cancer	0.000562	0.000562	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HDAC1—ocular cancer	0.00056	0.00056	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HDAC1—ocular cancer	0.000558	0.000558	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HDAC1—ocular cancer	0.000553	0.000553	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000549	0.000549	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—E2F1—ocular cancer	0.000534	0.000534	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CDKN2B—ocular cancer	0.000513	0.000513	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GNA11—ocular cancer	0.000506	0.000506	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CDKN2B—ocular cancer	0.000505	0.000505	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CDKN2B—ocular cancer	0.000504	0.000504	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CDKN2B—ocular cancer	0.000502	0.000502	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CDKN2B—ocular cancer	0.000501	0.000501	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CDKN2B—ocular cancer	0.000496	0.000496	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GNA11—ocular cancer	0.000476	0.000476	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—E2F1—ocular cancer	0.000471	0.000471	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GNAQ—ocular cancer	0.00047	0.00047	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—E2F1—ocular cancer	0.000463	0.000463	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—E2F1—ocular cancer	0.000462	0.000462	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—E2F1—ocular cancer	0.000461	0.000461	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—E2F1—ocular cancer	0.000459	0.000459	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—E2F1—ocular cancer	0.000455	0.000455	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000443	0.000443	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MDM2—ocular cancer	0.000437	0.000437	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MDM2—ocular cancer	0.000413	0.000413	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—HRAS—ocular cancer	0.000406	0.000406	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GNA11—ocular cancer	0.000404	0.000404	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CDKN1B—ocular cancer	0.000399	0.000399	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MDM2—ocular cancer	0.000396	0.000396	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AKT1—ocular cancer	0.000395	0.000395	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—HRAS—ocular cancer	0.000384	0.000384	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CCND1—ocular cancer	0.000381	0.000381	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CDKN1B—ocular cancer	0.000377	0.000377	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000375	0.000375	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AKT1—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CDKN1A—ocular cancer	0.000369	0.000369	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—HRAS—ocular cancer	0.000367	0.000367	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CDKN1B—ocular cancer	0.000361	0.000361	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCND1—ocular cancer	0.00036	0.00036	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AKT1—ocular cancer	0.000359	0.000359	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AKT1—ocular cancer	0.000357	0.000357	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EP300—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CDKN1A—ocular cancer	0.000348	0.000348	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCND1—ocular cancer	0.000345	0.000345	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AKT1—ocular cancer	0.000339	0.000339	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CDKN1A—ocular cancer	0.000333	0.000333	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EP300—ocular cancer	0.000331	0.000331	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000322	0.000322	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EP300—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MYC—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—ocular cancer	0.000305	0.000305	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000303	0.000303	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.0003	0.0003	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MYC—ocular cancer	0.000289	0.000289	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MDM2—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MDM2—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MDM2—ocular cancer	0.000278	0.000278	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MYC—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MDM2—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—EP300—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HRAS—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HRAS—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HRAS—ocular cancer	0.000258	0.000258	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HRAS—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CDKN1B—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CDKN1B—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CDKN1B—ocular cancer	0.000253	0.000253	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000253	0.000253	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCND1—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCND1—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCND1—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HRAS—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCND1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CDKN1A—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CDKN1A—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CDKN1A—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EP300—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—ocular cancer	0.000228	0.000228	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HRAS—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MYC—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EP300—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EP300—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EP300—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EP300—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EP300—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HRAS—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—ocular cancer	0.0002	0.0002	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MYC—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MYC—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MYC—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MYC—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MYC—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MYC—ocular cancer	0.000192	0.000192	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—ocular cancer	0.000192	0.000192	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—ocular cancer	0.000192	0.000192	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HRAS—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—EP300—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—ocular cancer	0.000159	0.000159	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—EP300—ocular cancer	0.000159	0.000159	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HRAS—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—HRAS—ocular cancer	0.000154	0.000154	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HRAS—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HRAS—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HRAS—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HRAS—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—EP300—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—ocular cancer	0.000133	0.000133	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—ocular cancer	9.62e-05	9.62e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—ocular cancer	8.15e-05	8.15e-05	CbGpPWpGaD
